Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FCGR3B | O75015 | 1/20 | 0.53 |
| ▸ | FCGR1A | P12314 | 1/20 | 0.53 |
| ▸ | FCGR2A | P12318 | 1/20 | 0.53 |
| ▸ | SYK | P43405 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 4/20 | 0.43 |
| ▸ | CA1 | P00915 | 4/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | CA9 | Q16790 | 4/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
| ▸ | STAT6 | P42226 | 3/20 | 0.39 |
| ▸ | ITK | Q08881 | 3/20 | 0.39 |
| ▸ | EGFR | P00533 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4518275 | 0.88 | FCGR3B (0.52) | FCGR3BFCGR1AFCGR2ASYKBRD4 | |
| SCHEMBL13921829 | 0.86 | FCGR3B (0.51) | FCGR3BFCGR1AFCGR2ASYKBRD4 | |
| SCHEMBL4522396 | 0.82 | SYK (0.56) | SYKBRD4EGFRMETNPR3 | |
| SCHEMBL13921823 | 0.78 | SYK (0.55) | SYKCA12CA1CA2CA9 | |
| SCHEMBL2123644 | 0.76 | BCHE (0.41) | CA12CA1CA2CA9CA14 | |
| SCHEMBL21091247 | 0.75 | MAPT (0.56) | CA1CA2 | |
| SCHEMBL29660117 | 0.75 | MAPT (0.56) | CA1CA2 | |
| SCHEMBL13921831 | 0.74 | RAB9A (0.51) | SYKBRD4 | |
| SCHEMBL13921798 | 0.74 | FCGR3B (0.84) | FCGR3BFCGR1AFCGR2ASYKCA1 | |
| SCHEMBL13421360 | 0.74 | FCGR3B (0.81) | FCGR3BFCGR1AFCGR2ACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090068169-A1 | 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use | PROMETIC BIOSCIENCES INC. (CA) | 2009-03-12 | — | — | US | disclosed |
| US-20090068169-A1 | 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use | PROMETIC BIOSCIENCES INC. (CA) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068169-A1 | 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use | FCGR2A, FCGR3B, FCGR1A | FCGR3B 2/4885FCGR1A 3/4885FCGR2A 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.